Cite
HARVARD Citation
Zhang, Y. et al. (n.d.). Assessment of pharmacokinetic interaction between rilotumumab and epirubicin, cisplatin and capecitabine (ECX) in a Phase 3 study in gastric cancer. British journal of clinical pharmacology. pp. 1048-1055. [Online].